arginine has been researched along with Coronary Heart Disease in 135 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (8.15) | 18.7374 |
| 1990's | 36 (26.67) | 18.2507 |
| 2000's | 68 (50.37) | 29.6817 |
| 2010's | 19 (14.07) | 24.3611 |
| 2020's | 1 (0.74) | 2.80 |
| Authors | Studies |
|---|---|
| Furey, A; Liu, M; Rahman, P; Randell, EW; Sun, G; Werdyani, S; Zhai, G; Zhang, H | 1 |
| Hansen, TW; Jacobsen, PK; Parving, HH; Persson, F; Reinhard, H; Rossing, P; Teerlink, T; von Scholten, BJ; Zobel, EH | 1 |
| Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA | 1 |
| Borzak, S; DeMets, D; Hennekens, CH; Hetzel, S; Schneider, R; Schneider, W; Schröder, H; Serebruany, V | 1 |
| Aijälä, M; Bloigu, R; Kesäniemi, YA; Santaniemi, M; Ukkola, O | 1 |
| Aydın, M; Can, G; Karagöz, A; Köroğlu, B; Onat, A; Yüksel, M | 1 |
| Baghestani, AR; Hosseini, S; Miri, R; Mokhtari, Z; Nasrollahzadeh, J; Rismanchi, M; Zahedirad, M | 1 |
| Chang, P; Cooke, JP; Ghebremariam, YT; Khan, F; Leeper, NJ; Nead, KT; Shah, NH; Thakker, RN | 1 |
| Almasy, L; Blangero, J; Curran, JE; DiStefano, JK; Duggirala, R; Hanson, RL; Kobes, S; Lehman, DM; Leti, F; Puppala, S; Tsinajinnie, D | 1 |
| Huang, S; Jiang, X; Peng, W; Shao, K; Tang, Y; Xia, L; Zou, D | 1 |
| Surdacki, A | 1 |
| Bode-Böger, SM; Goette, A; Jentsch-Ullrich, K; Lendeckel, U; Martens-Lobenhoffer, J; Scalera, F; Wolfram, O | 1 |
| Ajtay, Z; Awiszus, F; Bode-Böger, SM; Cziráki, A; Horváth, I; Martens-Lobenhoffer, J; Papp, L; Scalera, F; Sulyok, E; Szabo, C | 1 |
| Li, J; Li, ZQ; Pan, W; Wang, LF | 1 |
| Cavusoglu, E; Chopra, V; Eng, C; Frishman, WH; Marmur, JD; Pinsky, DJ; Poludasu, S; Ruwende, C; Yanamadala, S | 1 |
| Alioğlu, E; Altintaş, N; Berdeli, A; Cam, SF; Sekuri, C; Taşkiran, P; Tüzün, N | 1 |
| Cao, Y; Ouyang, M; Xiao, L; Yang, K; Zhang, Z | 1 |
| Ilic, MD; Ilic, S; Kocic, G; Lazarevic, G; Pavlovic, R; Stefanovic, V | 1 |
| Boehm, BO; Drechsler, C; Kielstein, JT; März, W; Meinitzer, A; Pilz, S; Ritz, E; Winkelmann, BR | 1 |
| SHAO, JM; WANG, DW; YOU, L; ZHANG, L; ZHAO, CX | 1 |
| Pendyala, L; Superko, R; Williams, P | 1 |
| Atzeni, F; Battellino, M; Boccassini, L; De Gennaro Colonna, V; Marchesoni, A; Sarzi-Puttini, P; Sitia, S; Tomasoni, L; Turiel, M | 1 |
| Alberti, L; Cancello, R; Di Blasio, AM; Gilardini, L; Invitti, C; Mencarelli, M; Zulian, A | 1 |
| Böger, R; Breitling, LP; Brenner, H; Koenig, W; Maas, R; Rothenbacher, D; Schwedhelm, E; Siegerink, B; Vossen, CY | 1 |
| Breddin, HK | 1 |
| Kelm, M | 1 |
| Busch, M; Franke, S; Kientsch-Engel, R; Müller, A; Sommer, M; Stein, G | 1 |
| Bates, ER; Weitz, JI | 1 |
| Califf, RM; O'Shea, S; Reddan, D; Szczech, LA | 1 |
| McGrath, BP; Teede, HJ | 1 |
| Crake, T; Davies, GJ; Goumas, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Kaplan, KL | 1 |
| Fujita, M; Hori, M; Kitakaze, M; Nanto, S; Node, K | 1 |
| Lewis, BE; Walenga, JM | 1 |
| Batra, S; Forslid, A; Kovanen, P; Liuba, P; Paakkari, I; Pentikäinen, M; Persson, K; Pesonen, E; Sandström, S | 1 |
| DIVERSI, R | 1 |
| Lincoff, AM | 1 |
| Jang, IK; Kathiresan, S; Wykrzykowska, JJ | 1 |
| Ding, YA; Lee, WS; Lin, SJ; Lu, TM; Tai, HC | 1 |
| Isomustajärvi, M; Laakso, J; Laaksonen, R; Lakka, TA; Lehtimäki, T; Päivä, H; Ruokonen, I; Salonen, JT; Valkonen, VP | 1 |
| Böger, RH; Hanefeld, C; Mügge, A | 1 |
| Böger, RH | 1 |
| Bartus, S; Dembinska-Kiec, A; Dubiel, JS; Dudek, D; Heba, G; Huk, I; Kaluza, GL; Legutko, J; Partyka, L | 1 |
| Selley, ML | 1 |
| Briggs, PJ; Day, IN; Ebrahim, S; Gaunt, TR; Hinks, LJ; Kiessling, M; Lawlor, DA; Smith, GD; Timpson, N | 1 |
| Hayashida, Y; Morishita, T; Nakashima, Y; Nakata, S; Sasaguri, Y; Suda, O; Tasaki, H; Toyohira, Y; Tsujimoto, T; Tsutsui, M; Ueno, S; Ueta, Y; Yanagihara, N | 1 |
| Daikoku, S; Goto, Y; Itoh, A; Itoh, T; Miyazaki, S; Morii, I; Nonogi, H | 1 |
| Nishio, I; Tsuda, K | 1 |
| Arnesen, H; Eid, HM; Hjerkinn, EM; Lyberg, T; Seljeflot, I | 1 |
| Bhatt, DL; Gurm, HS | 1 |
| Jang, IK; Kleiman, NS; Lewis, BE; Matthai, WH | 1 |
| Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH | 1 |
| Naidoo, D; Salonikas, C; Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
| Bolad, I; Delafontaine, P | 1 |
| Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Jachmann, N; Lackner, KJ; Lubos, E; Münzel, T; Peetz, D; Post, F; Rupprecht, HJ; Schnabel, R; Tiret, L | 1 |
| Bykhovsy, E; Chernihovsky, T; Keren, G; Koifman, B; Megidish, R; Topilski, I; Zelmanovich, L | 1 |
| Bartling, A; Böger, RH; Daniel, WG; Goudeva, L; Hanefeld, C; Kusus, M; Lenzen, H; Maas, R; Maisch, B; Mügge, A; Osterziel, KJ; Schmidt-Lucke, C; Schulze, F; Schwedhelm, E; Simon, BC; Streichert, T; Strödter, D; Tillmanns, H | 1 |
| Brodde, OE; Philipp, T | 1 |
| Karu, I; Starkopf, J; Zilmer, K; Zilmer, M | 1 |
| Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Kushnir, MM; May, HT; Muhlestein, JB; Nielson, R; Pasquali, M; Roberts, WL; Rockwood, AL; Schwarz, EL | 1 |
| Boehm, BO; Halwachs-Baumann, G; März, W; Meinitzer, A; Seelhorst, U; Wellnitz, B; Winkelmann, BR | 1 |
| Kuo, L; Parker, J; Ren, Y; Shipley, R; Thengchaisri, N | 1 |
| Baumert, J; Böger, RH; Hamraz, K; Koenig, W; Löwel, H; Maas, R; Schulze, F; Schwedhelm, E | 1 |
| Branzi, A; Coccolo, F; Cooke, JP; Fallani, F; Ferrara, R; Grigioni, F; Lewis, DB; Magelli, C; Magnani, G; Mocarski, ES; Potena, L; Valantine, HA | 1 |
| Kenemans, P; Teerlink, T; van der Mooren, MJ; Verhoeven, MO; Zuijdgeest-van Leeuwen, SD | 1 |
| Kiani, AN; Mahoney, JA; Petri, M | 1 |
| Bartoli, M; Caldwell, RB; Caldwell, RW; El-Remessy, AB; Labazi, M; Platt, DH; Romero, MJ; Tawfik, HE | 1 |
| Balestrieri, ML; Crimi, E; D'Armiento, FP; Farzati, B; Fiorito, C; Giovane, A; Grimaldi, V; Minucci, PB; Napoli, C; Servillo, L | 1 |
| Blanché, H; Charpentier, G; Cohen, N; Froguel, P; Garin, MC; James, RW; Morabia, A; Passa, P; Ruiz, J; Vaisse, C | 1 |
| Blum, M; Bogomolny, N; Chernichowsky, T; Finkelstein, A; Iaina, A; Koifman, B; Laniado, S; Peer, G; Scherez, J; Wollman, Y | 1 |
| Bosnjak, ZJ; Coughlan, MG; Kampine, JP; Kenny, D; Montgomery, RR; Warltier, DC | 1 |
| Egashira, K; Kasuya, H; Muramatsu, K; Numaguchi, K; Takahashi, T; Takeshita, A | 1 |
| Egashira, K; Hirooka, Y; Imaizumi, T; Kai, H; Sugimachi, M; Tagawa, T; Takeshita, A | 1 |
| Herrman, JP; Serruys, PW | 1 |
| Canty, JM; Smith, TP | 1 |
| Ferguson, JJ; Igo, SR; Macris, MP; Ober, JC; Willerson, JT; Yao, SK | 1 |
| Donkin, J; Iaffaldano, R; Lewis, BE; McKiernan, TL; Rao, L; Wallenga, JM | 1 |
| Morishima, N | 1 |
| Bode-Böger, SM; Böger, RH; Frölich, JC; Heinzel, D; Höper, MM; Mügge, A | 1 |
| Assmann, G; Beucler, I; Bruckert, E; Funke, H; Turpin, G; von Eckardstein, A; Wiebusch, H | 1 |
| Boileau, C; Erlich, D; Giraudet, P; Jondeau, G; Junien, C; Krempf, M; Rabès, JP; Saint-Jore, B; Varret, M | 1 |
| Arita, M; Hamada, M; Hano, T; Imanishi, T; Nishio, I; Tomobuchi, Y | 1 |
| Bauters, C; Bertrand, ME; Lablanche, JM; Meurice, T; Van Belle, E | 1 |
| Brett, SE; Chowienczyk, PJ; Jenkins, BS; Kneale, BJ; Paganga, G; Ritter, JM | 1 |
| Fujii, K; Koide, M; Matsuo, M; Matsuo, T; Sakamoto, S; Suzuki, S | 1 |
| Meyer, EC; Palant, A | 1 |
| Arca, M; Campa, PP; Campagna, F; Candeloro, A; Cantini, R; Montali, A; Ombres, D; Pannitteri, G; Ricci, G; Seccareccia, F | 1 |
| Bhagat, K | 1 |
| Gupta, R; Usher, D; Virgil, D; Ye, SQ; Yochim, SE; Zhang, LQ | 1 |
| Enderle, MD; Füllhase, J; Häring, HU; Karsch, KR; Koch, M; Kühn, R; Pfohl, M | 1 |
| Crake, T; Davies, GJ; Katsimaglis, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Britten, MB; Schächinger, V; Zeiher, AM | 1 |
| Matthai, WH | 1 |
| Cannon, PJ | 1 |
| Cooke, JP | 1 |
| Baumann, G; Cascorbi, I; Hauner, H; Laule, M; Roots, I; Stangl, K; Stangl, V; Vogt, M; Wernecke, K; Ziemer, S | 1 |
| Blum, A; Cannon, RO; Csako, G; Hathaway, L; Kirby, M; Mincemoyer, R; Panza, JA; Schenke, WH; Waclawiw, MA | 1 |
| Gray, GA; Megson, IL; Miller, AA | 1 |
| Feskens, EJ; Kok, FJ; Kromhout, D; Oomen, CM; van Erk, MJ | 1 |
| Baumann, G; Cascorbi, I; Laule, M; Meisel, C; Mrozikiewicz, PM; Roots, I; Rutsch, W; Stangl, K; Stangl, V; Wernecke, K; Ziemer, S | 1 |
| Chan, N; Vallance, P | 1 |
| Feskens, EJ; Hogendoorn, E; Kromhout, D; Menotti, A; Oomen, CM | 1 |
| Kelm, M; Rath, J | 1 |
| Endo, H; Fujiki, T; Ide, H; Imamura, K; Sato, M; Sudo, K | 1 |
| Hoyt, GE; Jahncke, CL; Kown, MH; Robbins, RC; Rothbard, JB; Uemura, S; van Der Steenhoven, T | 1 |
| Iannuzzi, A; Iannuzzo, G; Iorio, D; Mancini, M; Pauciullo, P; Rubba, P; Sapio, C; Spampinato, N | 1 |
| Davies, GJ; Goumas, G; Stefanadis, C; Tentolouris, C; Tousoulis, D; Toutouzas, P | 1 |
| Blum, A; Cannon, RO | 1 |
| Sztuka-Pietkiewicz, A; Zdrojewicz, Z | 1 |
| Cooke, JP; Fitzgerald, PJ; Hayase, M; Hibi, K; Hosokawa, H; Suzuki, T; Yeung, AC; Yock, PG; Yokoya, K | 1 |
| Dager, WE; White, RH | 1 |
| Anker, SD; Coats, AJ; Dietz, R; Francis, DP; Gläser, C; Greiser, P; Gross, M; Norwig, A; Rauchhaus, M; Schulz, S; Weidhase, L | 1 |
| Brzosko, S; de Gaetano, G; Iacoviello, L; Krauze-Brzosko, K | 1 |
| Wittkowsky, AK | 1 |
| Borisov, VG; Kukes, VG; Mashkovskiĭ, MD; Paskhina, TS; Shvarts, GIa | 1 |
| Amos, EC; Douglas, AM; Gervais, A; Rau, EE; Shine, KI | 1 |
| Eaton, RP; Lueker, R; Schade, DS | 1 |
| Adnot, S; Castaigne, A; Chabrier, PE; Dubois-Randé, JL; Geschwind, H; Zelinsky, R | 1 |
| Kostic, MM; Schrader, J | 1 |
| Lefer, AM; Ma, XL; Weyrich, AS | 1 |
| Dzhaliashvili, IV; Konorev, EA; Lakomkin, VL; Medvedeva, NV; Saks, VA | 1 |
| Schrör, K; Woditsch, I | 2 |
| Hirase, T; Kario, K; Kobayashi, H; Matsuo, T; Miki, T; Sakamoto, S; Yamada, T | 1 |
| Bassenge, E | 1 |
| Collen, D; Fallon, JT; Gold, HK; Guerrero, JL; Holt, R; Jang, IK; Leinbach, RC; Yaoita, H; Yasuda, T | 1 |
| Chesebro, JH; Fuster, V | 1 |
| Fitzgerald, DJ; Fitzgerald, GA | 1 |
| Allison, P; Ashton, J; Buja, LM; Eidt, JF; Golino, P; McNatt, J; Noble, S; Willerson, JT | 2 |
| Kapel'ko, VI; Lakomkin, VL; Makhotina, LA; Saks, VA; Shteĭnshneĭder, AIa | 1 |
| Asafov, GB; Chernousova, GB; Cherpachenko, NM; Chumachenko, MN; Krivov, VI; Merimson, VG; Mozzhechkov, VT; Ovchinnikov, IA; Rozynov, VG; Smirnov, VN | 1 |
| Brecher, AS; Burkholder, DE; Burkholder, JS; Howe, WF | 1 |
| Byers, SO; Friedman, M; Neuman, R; Rosenman, RH | 1 |
29 review(s) available for arginine and Coronary Heart Disease
| Article | Year |
|---|---|
L-arginine analogs--inactive markers or active agents in atherogenesis?
Topics: Arginine; Atherosclerosis; Biomarkers; Coronary Disease; Endothelium, Vascular; Humans; Inflammation; Nitric Oxide; Oxidative Stress | 2008 |
Cardiovascular involvement in psoriatic arthritis.
Topics: Antirheumatic Agents; Arginine; Arthritis, Psoriatic; Coronary Circulation; Coronary Disease; Cytokines; Heart Diseases; Humans; Inflammation; Microcirculation; Risk Factors; Tumor Necrosis Factor-alpha | 2011 |
[Experimental and clinical results with the thrombin inhibitor Argatroban].
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Coronary Disease; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
The L-arginine-nitric oxide pathway in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Arteries; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Prognosis; Vasomotor System | 2003 |
Direct thrombin inhibitors in cardiac disease.
Topics: Arginine; Coronary Disease; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Randomized Controlled Trials as Topic; Recombinant Proteins; Sulfonamides; Thrombin | 2003 |
Direct thrombin inhibitors.
Topics: Antithrombins; Arginine; Coronary Disease; Half-Life; Hirudins; Humans; Metabolic Clearance Rate; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Venous Thrombosis | 2003 |
[ADMA (asymmetric dimethyl arginine) and coronary artery disease].
Topics: Animals; Arginine; Coronary Disease; Humans | 2003 |
Argatroban in HIT type II and acute coronary syndrome.
Topics: Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Disease; Humans; Myocardial Infarction; Pipecolic Acids; Sulfonamides; Thrombocytopenia | 2002 |
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thrombolytic Therapy | 2003 |
Plasma concentration of asymmetric dimethylarginine and the risk of coronary heart disease: rationale and design of the multicenter CARDIAC study.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Enzyme Inhibitors; Follow-Up Studies; Humans; Nitric Oxide; Prospective Studies; Risk Factors; Vasodilation | 2003 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke | 2004 |
The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysis.
Topics: Aged; Arginine; Aryldialkylphosphatase; Cohort Studies; Coronary Disease; Female; Glutamine; Humans; Male; Middle Aged; Polymorphism, Genetic; United Kingdom | 2004 |
Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Disease; Heparin; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Syndrome; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis | 2005 |
Endothelial dysfunction: its role in hypertensive coronary disease.
Topics: Angiotensin II; Antihypertensive Agents; Arginine; Coronary Disease; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Nitric Oxide; Oxidants | 2005 |
[Role of the L-arginine/nitric oxide system in the action of nebivolol].
Topics: Adrenergic beta-Antagonists; Arginine; Benzopyrans; Coronary Disease; Ethanolamines; Heart Failure; Humans; Hypertension; Nebivolol; Nitric Oxide; Receptors, Adrenergic, beta; Sympathetic Nervous System; Vasodilator Agents | 2006 |
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome].
Topics: Animals; Arginine; Clinical Trials as Topic; Coronary Disease; Cytomegalovirus Infections; Disease Models, Animal; Endothelium, Vascular; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hypolipidemic Agents; Immunosuppression Therapy; Immunosuppressive Agents; Metabolic Syndrome; Quality of Life; Risk Assessment; Risk Factors; Rodentia; Stents; Time Factors | 2007 |
Thrombin and antithrombotic therapy in interventional cardiology.
Topics: Angioplasty, Balloon, Coronary; Animals; Antithrombins; Arginine; Coronary Disease; Fibrinolytic Agents; Heparin; Hirudin Therapy; Humans; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombin | 1994 |
Modulation of coronary autoregulatory responses by endothelium-derived nitric oxide.
Topics: Animals; Arginine; Constriction, Pathologic; Coronary Circulation; Coronary Disease; Dogs; Homeostasis; Humans; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase | 1995 |
[Endothelial dysfunction in cardiovascular diseases: therapeutic implications after coronary angioplasty].
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Endothelium, Vascular; Growth Substances; Humans; Hyperplasia; Nitric Oxide; Recurrence; Tunica Intima | 1997 |
Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arginine; Arteriosclerosis; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Exercise; Gonadal Steroid Hormones; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Nitric Oxide; Smoking; Superoxides; Vasoconstriction; Vasodilation | 1999 |
The role of nitric oxide in cardiac transplantation.
Topics: Animals; Apoptosis; Arginine; Coronary Disease; Graft Rejection; Heart Transplantation; Humans; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Postoperative Complications | 1999 |
The endothelium: a new target for therapy.
Topics: Arginine; Arteriosclerosis; Coronary Disease; Endothelium, Vascular; Humans; Nitric Oxide; Vasodilation; Vasodilator Agents | 2000 |
Endothelial function and nitric oxide: clinical relevance.
Topics: Arginine; Cardiovascular Diseases; Coronary Disease; Endothelium, Vascular; Genetic Therapy; Humans; Nitric Oxide; omega-N-Methylarginine; Risk Factors; Sepsis; Vasoconstriction | 2001 |
Endothelial dysfunction in human coronary circulation: relevance of the L-arginine-NO pathway.
Topics: Arginine; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Humans; Nitric Oxide | 2001 |
l-Arginine for the prevention and treatment of coronary artery disease.
Topics: Arginine; Coronary Disease; Humans; Nitric Oxide | 2001 |
[The role of beta 3-adrenergic receptors in the human organism].
Topics: Arginine; Coronary Disease; Cytosine; Diabetes Mellitus; Energy Metabolism; Humans; Hypertension; Lipolysis; Mutation; Obesity; Receptors, Adrenergic, beta-3; Thermogenesis; Thymidine; Tryptophan | 2001 |
Treatment of heparin-induced thrombocytopenia.
Topics: Animals; Anticoagulants; Arginine; Chondroitin Sulfates; Clinical Trials as Topic; Coronary Disease; Dermatan Sulfate; Drug Combinations; Female; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Pregnancy; Rabbits; Recombinant Proteins; Sulfonamides; Thrombocytopenia | 2002 |
The role of thrombin inhibition during percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Arginine; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Fibrinolytic Agents; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin | 2002 |
Clinical relevance of endothelium-derived relaxing factor (EDRF).
Topics: Animals; Arginine; Coronary Disease; Humans; Hypercholesterolemia; Hypertension; Nitric Oxide | 1992 |
18 trial(s) available for arginine and Coronary Heart Disease
| Article | Year |
|---|---|
Aspirin increases nitric oxide formation in chronic stable coronary disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Aspirin; Biomarkers; Cardiovascular Agents; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Heme Oxygenase-1; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Up-Regulation | 2013 |
Proton pump inhibitors and vascular function: A prospective cross-over pilot study.
Topics: Administration, Oral; Adult; Arginine; Biomarkers; California; Coronary Disease; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Lansoprazole; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Reproducibility of Results; Risk Assessment; Time Factors; Upper Extremity; Vasodilation; Young Adult | 2015 |
The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Antioxidants; Arginine; Cells, Cultured; Chromans; Coronary Disease; Endothelial Cells; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukocytosis; Male; Middle Aged; Oxidative Stress; Peroxidase; Umbilical Veins | 2010 |
Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease.
Topics: Aged; Amino Acid Substitution; Arginine; Asian People; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Coronary Disease; Female; Gene Frequency; Genotype; Humans; Hypolipidemic Agents; Lipids; Lysine; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Pravastatin; Treatment Outcome | 2009 |
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Linear Models; Male; Middle Aged; Mortality; Predictive Value of Tests; Prognosis; Renal Insufficiency; Risk Factors | 2011 |
Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels?
Topics: Acute Disease; Adult; Aged; Arginine; Atorvastatin; Biomarkers; Blood Glucose; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Finland; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Male; Middle Aged; Prospective Studies; Pyrroles; Risk Factors; Simvastatin; Statistics as Topic; Triglycerides | 2003 |
L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study.
Topics: Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Double-Blind Method; Humans; Hyperplasia; Male; Prospective Studies; Stents; Tunica Intima; Ultrasonography, Interventional | 2004 |
Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.
Topics: Aged; Angioplasty, Balloon; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Time Factors | 2004 |
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2005 |
Changes of plasma asymmetric dimethylarginine levels after coronary artery bypass grafting.
Topics: Arginine; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Female; Heart Arrest, Induced; Humans; Hyperoxia; Male; Middle Aged; Myocardium; Postoperative Period; Time Factors | 2006 |
Effects of a supplement containing isoflavones and Actaea racemosa L. on asymmetric dimethylarginine, lipids, and C-reactive protein in menopausal women.
Topics: Aged; Arginine; C-Reactive Protein; Cholesterol, LDL; Cimicifuga; Coronary Disease; Double-Blind Method; Female; Humans; Isoflavones; Lipids; Menopause; Sample Size | 2007 |
Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure.
Topics: Aged; Arginine; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Nitrates; Nitrites | 1995 |
Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans.
Topics: Acetylcholine; Aged; Aged, 80 and over; Arginine; Biological Availability; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Regional Blood Flow; Vasodilation | 1994 |
Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension.
Topics: Adult; Arginine; Blood Pressure; Coronary Disease; Cyclic GMP; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Signal Transduction; Vascular Resistance | 1996 |
Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease.
Topics: Acetylcholine; Administration, Oral; Adult; Aged; Arginine; Coronary Disease; Endothelium, Vascular; Female; Forearm; Humans; Hypercholesterolemia; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; Regional Blood Flow; Vasodilator Agents; Vitamin E | 1998 |
Oral L-arginine in patients with coronary artery disease on medical management.
Topics: Administration, Oral; Aged; Arginine; Cell Adhesion Molecules; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide; Treatment Outcome | 2000 |
Arginine intake and risk of coronary heart disease mortality in elderly men.
Topics: Aged; Analysis of Variance; Arginine; Cohort Studies; Coronary Disease; Diet; Humans; Male; Risk Factors | 2000 |
Effect of local delivery of L-arginine on in-stent restenosis in humans.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Prospective Studies; Stents; Ultrasonography, Interventional | 2002 |
88 other study(ies) available for arginine and Coronary Heart Disease
| Article | Year |
|---|---|
Endotypes of primary osteoarthritis identified by plasma metabolomics analysis.
Topics: Aged; Arginine; Body Mass Index; Carnitine; Case-Control Studies; Coronary Disease; Diabetes Mellitus; Factor Analysis, Statistical; Fasting; Female; Humans; Logistic Models; Lysophosphatidylcholines; Male; Metabolomics; Muscle Weakness; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoporosis; Palmitic Acid; Prevalence; Quality Control; Wasting Syndrome | 2021 |
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Topics: Adult; Aged; Albuminuria; Arginine; Cardiovascular Diseases; Coronary Disease; Creatinine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Risk Factors | 2017 |
Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease.
Topics: Arginine; Biomarkers; Coronary Disease; Humans; Odds Ratio; Recurrence; Risk Factors; ROC Curve; Syndrome | 2019 |
Leptin receptor Arg109 homozygotes display decreased total mortality as well as lower incidence of cardiovascular disease and related death.
Topics: Adult; Arginine; Cardiovascular Diseases; Coronary Disease; Female; Genotype; Homozygote; Humans; Incidence; Male; Middle Aged; Receptors, Leptin; Risk Factors | 2014 |
Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes.
Topics: Adult; Anthropometry; Arginine; Biomarkers; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Male; Metabolic Syndrome; Prospective Studies | 2014 |
Relationship between Dietary Approaches to Stop Hypertension score and Alternative Healthy Eating Index score with plasma asymmetrical dimethylarginine levels in patients referring for coronary angiography.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Coronary Stenosis; Cross-Sectional Studies; Diet; Energy Intake; Female; Health Promotion; Humans; Hypertension; Iran; Male; Middle Aged | 2015 |
The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3.
Topics: Adult; Alleles; Amino Acid Substitution; Angiopoietin-Like Protein 3; Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Arginine; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromosomes, Human, Pair 19; Cohort Studies; Coronary Disease; Diabetes Mellitus; Female; Genome-Wide Association Study; Hep G2 Cells; Humans; Indians, North American; Insulin; Male; Mexican Americans; Middle Aged; Peptide Hormones; Polymorphism, Single Nucleotide; Tryptophan | 2016 |
The prediction roles of asymmetric dimethyl-arginine, adiponectin and apelin for macroangiopathy in patients with impaired glucose regulation.
Topics: Adiponectin; Aged; Apelin; Arginine; Atherosclerosis; Blood Glucose; Coronary Disease; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Prediabetic State; Prognosis | 2016 |
Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA.
Topics: Aged; Arginine; Cardiovascular Surgical Procedures; Case-Control Studies; Coronary Disease; Down-Regulation; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide Synthase; Stents; Time Factors | 2009 |
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography.
Topics: Aged; Arginine; Coronary Angiography; Coronary Disease; Diabetes Complications; Humans; Male; Myocardial Infarction; Prognosis; Proportional Hazards Models; Stroke | 2010 |
[The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
Topics: Adult; Amino Acid Substitution; Arginine; Aryldialkylphosphatase; Codon; Coronary Disease; DNA Primers; Female; Gene Frequency; Genotype; Glutamine; Humans; Leucine; Male; Methionine; Middle Aged; Polymorphism, Genetic | 2009 |
Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Arginine; Biomarkers; Coronary Disease; Female; Humans; Male; Middle Aged; Nitric Oxide; von Willebrand Factor | 2010 |
Impact of reversible myocardial ischaemia on nitric oxide and asymmetric dimethylarginine production in patients with high risk for coronary heart disease.
Topics: Arginine; Coronary Disease; Diabetes Complications; Exercise Tolerance; Female; Humans; Male; Middle Aged; Nitric Oxide; Risk Factors; Ultrasonography | 2010 |
[Plasma asymmetric dimethylarginine and cystatin C levels in patients with coronary artery disease].
Topics: Aged; Arginine; Case-Control Studies; Coronary Disease; Cystatin C; Female; Humans; Male; Middle Aged | 2010 |
I've read a number of articles in recent years about nitric oxide (NO) and how it can help improve circulation. Can you explain how that works and are there supplements available or things I can do to improve NO levels in my body?
Topics: Arginine; Blood Pressure; Coronary Disease; Dietary Supplements; Health Knowledge, Attitudes, Practice; Hemodynamics; Humans; Nitric Oxide Donors | 2009 |
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.
Topics: Arginine; Canada; Case-Control Studies; Comparative Genomic Hybridization; Computer Simulation; Coronary Disease; Cross-Sectional Studies; Drug Interactions; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinesins; Logistic Models; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Prospective Studies; Research Design; Risk Assessment; Risk Factors; Selection Bias; Survival Analysis; Treatment Outcome; Tryptophan | 2011 |
A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity.
Topics: Animals; Arginine; Cell Line, Tumor; Coronary Disease; Diabetes Mellitus, Type 2; Female; Genetic Loci; Glycine; Heterozygote; Humans; Hypertension; Insulin-Secreting Cells; Mice; Middle Aged; Mutation, Missense; Obesity; Pedigree; Pro-Opiomelanocortin; Protein Sorting Signals; RNA Folding; RNA, Messenger | 2012 |
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Topics: Aged; Arginine; Biomarkers; Cause of Death; Chromatography, Liquid; Coronary Disease; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Tandem Mass Spectrometry; Time Factors | 2013 |
Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
Topics: Adult; Arginine; Coronary Disease; Cystathionine; Female; Glycation End Products, Advanced; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Logistic Models; Lysine; Male; Methylmalonic Acid; Middle Aged; Risk Factors | 2003 |
Anticoagulation in acute cardiac care in patients with chronic kidney disease.
Topics: Anticoagulants; Antithrombins; Arginine; Chronic Disease; Coronary Disease; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; United States | 2003 |
Oestrogen and the cardiovascular system.
Topics: Arginine; Cardiovascular Physiological Phenomena; Coronary Disease; Endothelium, Vascular; Estrogens, Conjugated (USP); Female; Humans; Lipid Metabolism; Male; Nitric Oxide; Nitric Oxide Synthase; Risk Factors; Selective Estrogen Receptor Modulators | 2003 |
Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.
Topics: Angina Pectoris; Arginine; Blood Flow Velocity; Cardiac Pacing, Artificial; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Stenosis; Coronary Vessels; Female; Humans; Male; Middle Aged; Vasodilator Agents | 2003 |
Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs.
Topics: Acute Disease; Animals; Arginine; Bradykinin; Chlamydophila Infections; Chlamydophila pneumoniae; Coronary Circulation; Coronary Disease; Coronary Vessels; Disease Models, Animal; Endothelium, Vascular; Glutathione; Nitric Oxide Synthase; Polymerase Chain Reaction; Probability; Reference Values; Swine; Vasoconstriction; Vasodilation | 2003 |
[CONTRIBUTION TO THE BIOCHEMICAL DIRECTOR OF THERAPY IN MYOCARDIAL INSUFFICIENCY].
Topics: Adenine Nucleotides; Arginine; Coronary Disease; Geriatrics; Hexosephosphates; Hypoxia; Myocardium; Niacin; Pathology; Respiratory Insufficiency; Thiamine | 1963 |
Clinician update: direct thrombin inhibitors in acute coronary syndromes.
Topics: Acute Disease; Arginine; Coronary Disease; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin | 2003 |
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Disease; Death, Sudden, Cardiac; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Myocardial Infarction; Nitric Oxide Synthase; Prospective Studies; Risk Factors; Survival Analysis | 2003 |
Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Topics: Aldehydes; Arginine; Citrulline; Coronary Disease; Depressive Disorder, Major; Female; Glutathione; Humans; Lipid Peroxidation; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites | 2004 |
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Coronary Disease; Enzyme Induction; Homocysteine; Imidazoles; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Olmesartan Medoxomil; omega-N-Methylarginine; Oxidative Stress; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Superoxides; Tetrazoles; Thiazepines | 2004 |
Serum homocysteine and endothelial dysfunction in circulatory disorders in women.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Myocardial Infarction; Nitric Oxide; Risk; Risk Factors | 2004 |
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.
Topics: Aged; Arginine; Arteriosclerosis; Coronary Disease; Cross-Sectional Studies; Enzyme Inhibitors; Humans; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Nitric Oxide Synthase; Obesity; Risk Factors; Smoking | 2004 |
Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Pipecolic Acids; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides | 2004 |
Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Topics: Adult; Aged; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Disease; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide Synthase; Prognosis; Retrospective Studies; Risk Factors; Smoking | 2006 |
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Creatinine; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors | 2005 |
Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease.
Topics: Administration, Oral; Aged; Angiotensin II Type 1 Receptor Blockers; Arginine; Brachial Artery; Coronary Disease; Drug Therapy, Combination; Endothelium, Vascular; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Losartan; Male; Middle Aged; Nitric Oxide; Treatment Outcome; Ultrasonography, Doppler; Vasodilation | 2006 |
Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study.
Topics: Aged; Arginine; Case-Control Studies; Coronary Disease; Female; Humans; Male; Middle Aged; Risk Factors | 2006 |
Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
Topics: Arginine; Biomarkers; Blood Glucose; C-Peptide; Case-Control Studies; Coronary Disease; Cortisone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Hyperinsulinism; Logistic Models; Male; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Predictive Value of Tests; Risk Assessment | 2007 |
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
Topics: Analysis of Variance; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Male; Middle Aged; Mortality; Predictive Value of Tests; Regression Analysis; Risk Factors | 2007 |
Exercise training restores coronary arteriolar dilation to NOS activation distal to coronary artery occlusion: role of hydrogen peroxide.
Topics: Animals; Arginine; Arterioles; Coronary Disease; Coronary Vessels; Enzyme Activation; Female; Hydrogen Peroxide; Nitric Oxide; Nitric Oxide Synthase; Oxidants; Physical Conditioning, Animal; Rest; Swine; Swine, Miniature; Vasodilation; Vasomotor System | 2007 |
Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Regi
Topics: Adult; Aged; Arginine; Case-Control Studies; Cell Line; Coronary Disease; Endothelium, Vascular; Female; Humans; Male; Mass Screening; Middle Aged; Nitric Oxide Synthase; Plasma; Prospective Studies; Risk; Smoking | 2007 |
Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus.
Topics: Adult; Antibodies, Antinuclear; Arginine; Biomarkers; Calcinosis; Coronary Angiography; Coronary Disease; Ethnicity; Female; Humans; Lipids; Lupus Erythematosus, Systemic; Male; Maryland; Prognosis; Risk Factors | 2007 |
Diabetes-induced coronary vascular dysfunction involves increased arginase activity.
Topics: Animals; Arginase; Arginine; Binding, Competitive; Cattle; Coronary Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus, Experimental; Endothelium, Vascular; Nitric Oxide Synthase Type III; Rats | 2008 |
Effect of L-arginine on circulating endothelial progenitor cells and VEGF after moderate physical training in mice.
Topics: Analysis of Variance; Animals; Arginine; Cell Movement; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Exercise Tolerance; Mice; Mice, Inbred C57BL; Models, Animal; Physical Conditioning, Animal; Probability; Random Allocation; Sensitivity and Specificity; Stem Cells; Vascular Endothelial Growth Factor A | 2008 |
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
Topics: Arginine; Aryldialkylphosphatase; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Esterases; Female; Genotype; Glutamine; Humans; Male; Middle Aged; Polymorphism, Genetic; Regression Analysis; Risk Factors | 1995 |
Cultured endothelial cells restore vasodilator responses to coronary arteries with impaired endothelial function and alter the response to a nitric oxide donor.
Topics: Animals; Arginine; Blood Flow Velocity; Calcimycin; Cells, Cultured; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Molsidomine; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Umbilical Veins; Vasodilator Agents | 1994 |
Effects of N-nitro-L-arginine on coronary artery tone and reactive hyperemia after brief coronary occlusion in conscious dogs.
Topics: Acetylcholine; Animals; Arginine; Blood Flow Velocity; Consciousness; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Hyperemia; Nitric Oxide; Nitroarginine; Vasodilation | 1994 |
Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Topics: Administration, Topical; Animals; Arginine; Coronary Circulation; Coronary Disease; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Injections, Intravenous; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Pericardium; Platelet Aggregation; Platelet Aggregation Inhibitors; Time Factors; Vasodilator Agents | 1996 |
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Female; Heparin; Humans; Myocardial Infarction; Pipecolic Acids; Platelet Aggregation Inhibitors; Stents; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis | 1996 |
The effects of modulation of the L-arginine-nitric oxide pathway on myocardial stunning following repetitive coronary occlusion in dogs.
Topics: Acetylcholine; Animals; Arginine; Coronary Circulation; Coronary Disease; Dogs; Enzyme Inhibitors; Female; Hemodynamics; Male; Myocardial Stunning; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Vasodilator Agents | 1995 |
The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano.
Topics: Adult; Aged; Apolipoprotein A-I; Arginine; Child; Cholesterol, HDL; Coronary Disease; Cysteine; Electrophoresis; Female; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Pedigree; Phenotype; Phosphatidylcholine-Sterol O-Acyltransferase; Point Mutation; Risk Factors; Sequence Analysis, DNA; Tangier Disease | 1997 |
Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.
Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Arginine; Coronary Disease; Cysteine; DNA Mutational Analysis; Female; France; Genetic Testing; Genetics, Population; Glutamine; Heterozygote; Humans; Hypercholesterolemia; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation; Polymerase Chain Reaction | 1997 |
Effects of locally administered argatroban on restenosis after balloon angioplasty: experimental and clinical study.
Topics: Angioplasty, Balloon; Animals; Antithrombins; Arginine; Cell Division; Coronary Disease; Humans; Muscle, Smooth, Vascular; Pipecolic Acids; Platelet Activation; Rabbits; Sulfonamides | 1997 |
Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Antithrombins; Arginine; Coronary Disease; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Stents; Sulfonamides; Thrombocytopenia | 1997 |
Arginine consumption in coronary disease.
Topics: Arginine; Cohort Studies; Coronary Disease; Humans; Risk Factors | 1998 |
The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
Topics: Adult; Arginine; Aryldialkylphosphatase; Coronary Disease; Esterases; Female; Gene Frequency; Genotype; Glutamine; Humans; Italy; Lipids; Male; Middle Aged; Polymorphism, Genetic | 1998 |
Endothelial dysfunction in cardiovascular disease.
Topics: Antioxidants; Arginine; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Humans; Hypolipidemic Agents; Nitric Oxide Synthase | 1998 |
A PstI polymorphism detects the mutation of serine128 to arginine in CD 62E gene - a risk factor for coronary artery disease.
Topics: Alleles; Amino Acid Substitution; Angiography; Arginine; Coronary Disease; Deoxyribonucleases, Type II Site-Specific; DNA Mutational Analysis; E-Selectin; Exons; Female; Gene Frequency; Heterozygote; Humans; Male; Middle Aged; Mutation; Polymorphism, Genetic; Reference Values; Serine | 1999 |
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Topics: Arginine; Aryldialkylphosphatase; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; DNA; Esterases; Female; Gene Frequency; Genotype; Glutamine; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Polymerase Chain Reaction; Polymorphism, Genetic | 1999 |
Effects of L- and D-arginine on the basal tone of human diseased coronary arteries and their responses to substance P.
Topics: Analysis of Variance; Arginine; Coronary Angiography; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Female; Humans; Isomerism; Male; Middle Aged; Nitroglycerin; Substance P; Vasodilator Agents | 1999 |
Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Coronary Disease; Drug Evaluation; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis | 1999 |
Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the beta3-adrenergic receptor.
Topics: Aged; Arginine; Body Mass Index; Coronary Disease; Female; Genotype; Humans; Insulin; Leptin; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Receptors, Leptin; Regression Analysis; Tryptophan | 2000 |
Inducible nitric oxide synthase-derived superoxide contributes to hypereactivity in small mesenteric arteries from a rat model of chronic heart failure.
Topics: Animals; Arginine; Coronary Disease; Dose-Response Relationship, Drug; Endothelium; Heart Failure; Immunohistochemistry; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Potassium Chloride; Rats; Rats, Wistar; Superoxides; Vasodilation | 2000 |
Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Atherectomy, Coronary; Cardiac Catheterization; Coronary Disease; Factor VII; Female; Glutamine; Humans; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Point Mutation; Polymorphism, Genetic; Risk Factors; Stents; Time Factors | 2000 |
Arginine intake and 25-year CHD mortality: the Seven Countries Study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Feeding Behavior; Humans; International Cooperation; Male; Middle Aged; Risk Factors | 2001 |
Off-pump coronary artery bypass for a heparin-allergic patient.
Topics: Anticoagulants; Arginine; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Drug Hypersensitivity; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Sulfonamides | 2001 |
L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation.
Topics: Animals; Aorta; Arginine; Cell Division; Cells, Cultured; Coronary Disease; Coronary Vessels; Heart Transplantation; Male; Myocardium; Nitric Oxide; Nitrites; Polymers; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Rats, Sprague-Dawley | 2001 |
L-arginine improves post-ischemic vasodilation in coronary heart disease patients taking vasodilating drugs.
Topics: Adult; Aged; Arginine; Coronary Disease; Glucose; Hemodynamics; Humans; Hyperemia; Infusions, Intravenous; Insulin; Insulin Secretion; Ischemia; Leg; Middle Aged; Regional Blood Flow; Rest; Vascular Resistance; Vasodilation; Vasodilator Agents | 2001 |
Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque.
Topics: Analysis of Variance; Arginine; Coronary Artery Disease; Coronary Disease; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Vasodilation; Vasodilator Agents | 2001 |
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Arginine; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Membrane Glycoproteins; Middle Aged; Myocardial Infarction; Polymorphism, Genetic; Predictive Value of Tests; Receptors, Fibroblast Growth Factor; Serine; Sialoglycoproteins; Treatment Outcome | 2002 |
Asymmetrical dimethylarginine and risk of acute coronary events.
Topics: Arginine; Coronary Disease; Endothelium, Vascular; Humans; Male; Risk Assessment; Risk Factors | 2002 |
[Mechanism of action and clinical effectiveness of the new Soviet-made drug parmidin in the treatment of arteriosclerosis and ischemic heart disease].
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aprotinin; Arginine; Arteriosclerosis; Benzamides; Blood Coagulation; Carbamates; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Enzyme Precursors; Esterases; Female; Humans; Kininogens; Lysine Carboxypeptidase; Male; Middle Aged; Pyridinolcarbamate; USSR | 1978 |
Enhanced mechanical recovery of anoxic and ischemic myocardium by amino acid perfusion.
Topics: Amino Acids; Animals; Arginine; Aspartic Acid; Coronary Disease; Creatine; Glutamates; Hypoxia; Male; Myocardial Contraction; Myocardium; Ornithine; Rabbits | 1979 |
Clofibrate-induced changes in glucagon and insulin secretion in patients with angiographically documented coronary artery disease.
Topics: Adult; Arginine; Clofibrate; Coronary Disease; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1977 |
L-arginine improves endothelium-dependent relaxation of conductance and resistance coronary arteries in coronary artery disease.
Topics: Acetylcholine; Arginine; Coronary Circulation; Coronary Disease; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypercholesterolemia; Vascular Resistance; Vasodilation | 1992 |
Role of nitric oxide in reactive hyperemia of the guinea pig heart.
Topics: Adenosine; Animals; Arginine; Coronary Circulation; Coronary Disease; Cyclic GMP; Hyperemia; In Vitro Techniques; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Spectrophotometry | 1992 |
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat.
Topics: Animals; Arginine; Cats; Cell Adhesion; Cell Movement; Coronary Disease; Coronary Vessels; Electrophysiology; Endothelium, Vascular; Heart; Hemodynamics; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Neutrophils; Peroxidase | 1992 |
[The role of calcium ions in the molecular mechanism of the protective mechanism of exogenous phosphocreatine].
Topics: Animals; Arginine; Calcium; Cations, Divalent; Coronary Disease; Electron Spin Resonance Spectroscopy; Heart; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Phosphocreatine; Rats; Rats, Inbred Strains; Spin Labels | 1992 |
Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia.
Topics: Animals; Arginine; Coronary Circulation; Coronary Disease; Creatine Kinase; Epoprostenol; Heart; Indomethacin; Myocardial Reperfusion; Myocardium; Nitric Oxide; Rabbits; Reference Values | 1992 |
Hereditary heparin cofactor II deficiency and coronary artery disease.
Topics: Angina Pectoris; Angiography; Angioplasty, Balloon, Coronary; Antithrombins; Arginine; Coronary Disease; Female; Heparin Cofactor II; Humans; Male; Middle Aged; Pedigree; Pipecolic Acids; Sulfonamides | 1992 |
Endogenous prostacyclin preserves myocardial function and endothelium-derived nitric oxide formation in myocardial ischemia.
Topics: Animals; Arginine; Blood Pressure; Coronary Circulation; Coronary Disease; Creatine Kinase; Epoprostenol; Heart; Heart Function Tests; In Vitro Techniques; Indomethacin; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Nitric Oxide; Nitroarginine; Rabbits | 1992 |
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Aspirin; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1990 |
Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
Topics: Animals; Antibodies, Monoclonal; Antithrombins; Arginine; Coronary Disease; Coronary Thrombosis; Dogs; Pipecolic Acids; Platelet Membrane Glycoproteins; Recurrence; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator | 1990 |
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
Topics: Animals; Antithrombins; Arginine; Coronary Disease; Coronary Thrombosis; Disease Models, Animal; Dogs; Phospholipases; Phospholipases A; Pipecolic Acids; Platelet Aggregation; Reperfusion; Sulfonamides; Thrombin; Tissue Plasminogen Activator | 1989 |
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
Topics: Animals; Antithrombin III; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hemodynamics; Heparin; Hydrazines; Ketanserin; Male; Peptide Hydrolases; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombin | 1989 |
[High specificity in the molecular mechanism of the protective action of phosphocreatine on the myocardium in ischemia].
Topics: Animals; Arginine; Cardiac Catheterization; Cats; Coronary Disease; Drug Evaluation, Preclinical; Heart; Hemodynamics; Lysophospholipids; Male; Myocardium; Organophosphorus Compounds; Phosphocreatine; Phospholipids; Rats; Rats, Inbred Strains; Spin Labels | 1988 |
Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
Topics: Animals; Antithrombins; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Fatty Acids, Unsaturated; Female; Heparin; Hydrazines; Ketanserin; Male; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Thrombin; Thromboxane A2 | 1988 |
Ammonia neutralization and urea synthesis in cardiac muscle.
Topics: Adult; Ammonia; Animals; Arginase; Arginine; Cardiac Catheterization; Coronary Disease; Coronary Vessels; Humans; Ligation; Male; Middle Aged; Myocardial Infarction; Myocardium; Ninhydrin; Nitrogen; Nitrogen Isotopes; Quaternary Ammonium Compounds; Rats; Urea | 1974 |
An evaluation of the utility of benzoyl-DL-arginine-beta-naphthyl-amide for the assay of thrombin activity in blood.
Topics: Animals; Arginine; Benzamides; Cattle; Coronary Disease; Coumarins; Factor VIII; Fibrinogen; Hirudins; Humans; Hydrolysis; Naphthalenes; Protein Binding; Prothrombin; Serum Albumin; Thrombin; Thromboplastin | 1974 |
Coronary-prone individuals (type A behavior pattern). Growth hormone responses.
Topics: Adult; Arginine; Behavior; Blood Glucose; Body Height; Body Weight; Central Nervous System; Cholesterol; Coronary Disease; Emotions; Endocrine Glands; Growth Hormone; Humans; Hypercholesterolemia; Male; Middle Aged; Pituitary Gland; Rest; Stress, Psychological; Triglycerides | 1971 |